Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky

Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky

IntroductionHigh-risk human epidermal growth factor receptor 2 (HER2)-positive adenocarcinomas associate with early recurrence and death, prompting consideration of novel radiotherapeutic options like a trastuzumab-linked thorium-227 alpha-particle emitting radionuclide.MethodsWe conducted a retrosp...

Full description

Bibliographic Details
Main Authors: Charles A. Kunos, Denise Fabian, Dava W. Piecoro, Dana Napier, Rachel W. Miller, Frederick R. Ueland
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
uterine cervical cancer
uterine cervical adenocarcinoma
HER2/neu
radiopharmaceutical
triage
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.948348/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.948348/full

Similar Items